Literature DB >> 35303526

Effects of social support on frailty trajectory classes among community-dwelling older adults: The mediating role of depressive symptoms and physical activity.

Yaru Jin1, Ruby Yu2, Huaxin Si1, Yanhui Bian1, Xiaoxia Qiao1, Lili Ji1, Qinqin Liu1, Wenyu Wang1, Jiaqi Yu1, Yanyan Li1, Cuili Wang3.   

Abstract

OBJECTIVES: To investigate whether and how social support influenced frailty progression through depressive symptoms and physical activity.
METHODS: Of 1235 community-dwelling older adults enrolled at baseline, 778 (63.0%) undergoing at least one yearly follow-up were included in the final analysis. Data were collected on frailty, social support, depressive symptoms, physical activity and covariates.
RESULTS: Two frailty trajectory classes were identified and labeled as alleviated frailty and deteriorated frailty. Subjective support prevented the deterioration of frailty through decreased depressive symptoms, while objective support and support utilization prevented the deterioration of frailty through increased physical activity.
CONCLUSIONS: The pathways through which social support ameliorates frailty vary by support types. Subjective support interventions should be included in the multifactorial interdisciplinary management of frailty to address social and psychological vulnerabilities, along with objective support and support utilization interventions addressing physical inactivity.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depressive symptoms; Frailty; Physical activity; Social support

Mesh:

Year:  2022        PMID: 35303526     DOI: 10.1016/j.gerinurse.2022.02.029

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.525


  1 in total

1.  Perceived Social Support and Associated Factors Among Community-Dwelling Older Adults With Frailty and Pre-frailty in Hangzhou, China.

Authors:  Juan Fang; Jianping Ren; Lixian Ren; Xiantao Qiu; Shuang Yuan; Wenting Wang; Jinjing Wang
Journal:  Front Psychiatry       Date:  2022-07-14       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.